BONOMINI, Mario
 Distribuzione geografica
Continente #
NA - Nord America 5046
EU - Europa 4742
AS - Asia 2363
Continente sconosciuto - Info sul continente non disponibili 14
SA - Sud America 1
Totale 12166
Nazione #
US - Stati Uniti d'America 5021
CN - Cina 1206
UA - Ucraina 1135
TR - Turchia 824
IT - Italia 762
SE - Svezia 738
GB - Regno Unito 575
IE - Irlanda 497
FR - Francia 389
DE - Germania 363
IN - India 253
FI - Finlandia 199
VN - Vietnam 55
BE - Belgio 39
CA - Canada 23
RU - Federazione Russa 15
EU - Europa 14
IR - Iran 12
PL - Polonia 12
IL - Israele 8
ES - Italia 3
AT - Austria 2
DK - Danimarca 2
GR - Grecia 2
MK - Macedonia 2
NL - Olanda 2
PA - Panama 2
RO - Romania 2
BD - Bangladesh 1
CH - Svizzera 1
CL - Cile 1
CZ - Repubblica Ceca 1
HR - Croazia 1
JP - Giappone 1
KR - Corea 1
MY - Malesia 1
SG - Singapore 1
Totale 12166
Città #
Jacksonville 1279
Chandler 1086
Princeton 519
Dublin 493
Southend 450
Izmir 418
Nanjing 355
Houston 338
Wilmington 276
Dearborn 223
Cambridge 210
Chieti 179
Beijing 163
Altamura 145
Nanchang 143
Ann Arbor 130
Woodbridge 99
Shenyang 77
Hebei 70
Boardman 57
Dong Ket 55
Jiaxing 54
Tianjin 54
Kunming 50
Brussels 39
Jinan 35
Norwalk 32
Hangzhou 30
Vittuone 29
Ningbo 28
Changsha 27
Grevenbroich 23
Zhengzhou 21
Leawood 20
Augusta 19
Düsseldorf 17
Kocaeli 17
San Mateo 17
Hefei 16
Ottawa 16
Orange 15
Lanzhou 14
Taizhou 13
Ardabil 12
Guangzhou 12
Kraków 11
Rome 11
Falls Church 10
Taranto 10
Ferrara 9
Martinsicuro 9
Changchun 8
Los Angeles 8
Auburn Hills 7
Fuzhou 7
Helsinki 7
Pescara 7
Simi Valley 7
Cedar Knolls 6
Bangalore 5
Milan 5
Omegna 5
Shanghai 5
Cepagatti 4
Hanover 4
London 4
Perugia 4
Redmond 4
San Vito Chietino 4
Toronto 4
Walnut 4
Xian 4
Andover 3
Ashburn 3
Bologna 3
Buccinasco 3
Carmiano 3
Fermo 3
Guardiagrele 3
Iseo 3
Jesi 3
Madrid 3
Menlo Park 3
Monmouth Junction 3
Montesilvano 3
Napoli 3
Nürnberg 3
San Jose 3
Scafati 3
Torrevecchia Teatina 3
Bari 2
Carovigno 2
Casalgrande 2
Catania 2
Cerea 2
Città Di Castello 2
Collecorvino 2
Concarneau 2
Fino Mornasco 2
Frankfurt am Main 2
Totale 7622
Nome #
null 358
Therapy of glucocorticoid induced osteoporosis 121
Epatotossicità acuta da amiodarone endovena in una paziente in emodialisi 110
Cell activation and cellular-cellular interactions during hemodialysis: effect of dialyzer membrane 103
Adherence of Uremic Erythrocytes to Vascular Endothelium decreases Endothelial Nitric Oxide Synthase Expression 101
Prognostic value of morphologic and morphometric analyses in IgA nephropathy biopsies 100
Platelet-leukocyte interactions in hemodialysis patients: culprit or bystander? 98
Effect of an L-carnitine-containing peritoneal dialysate on insulin sensitivity in patients treated with CAPD: a 4-month, prospective, multicenter randomized trial. 98
Nephrotoxicity induced by chemotherapy [Nefrotossicita' da chemioterapici] 96
Valutazione dell'utilità del test al Captopril nella diagnostica dell'ipertensione renovascolare (IRV) 96
Alterazioni eritrocitarie e loro possibile ruolo nelle complicanze cardiovascolari dell’uremia 96
Proteomic analysis of protein adsorption capacity of different haemodialysis membranes 93
Proteomics characterization of protein adsorption onto hemodialysis membranes 92
Angiodysplasia of the small bowel: a possible cause of anemia even in mild chronic renal failure 91
Calcimimetic R-568 vasodilatory effect effect on mesenteric vascular beds from normotensive (WKY) and spontaneously hypertensive (SHR) rats. Potential involvement of vascular smooth muscle cells (vSMCs) 89
Plasma protein carbonylation in chronic uremia 88
Calcium Sensing Receptor Expression in Ovine Amniotic Fluid Mesenchymal Stem Cells and the Potential Role of R-568 during Osteogenic Differentiation 88
Mechanisms of uremic erytrocyte-induced adhesion of human monocytes to cultured endothelial cells 87
Proteomic investigations on the effect of different membrane materials on blood protein adsorption during haemodialysis 86
Emodiafiltrazione (HDF) con polisulfone (PSF) e neuropatia periferica: una valida alternativa al trattamento emodialitico tradizionale RDT) 85
Thyroid function and plasma selenium in chronic uremic patients onhemodialysis treatment 85
L-carnitine inhibits a subset of platelet activation responses in chronic uraemia 84
Elettrofisiologia del sistema nervoso centrale e periferico in pazienti in trattamento sostitutivo: effetti della RDT e della CAPD 83
On-line HFR and removal of uremic toxins inducing the loss of phospholipidic asymmetry of the erythrocyte membrane [HFR on-line e rimozione di tossine uremiche inducenti la perdita dell'asimmetria fosfolipidica della membrana eritrocitaria.] 83
Adsorption and carbonylation of plasma proteins by dialyser membrane material: in vitro and in vivo proteomics investigations 83
Phylogenetic relationships, biofilm formation, motility, antibiotic resistance and extended virulence genotypes among Escherichia coli strains from women with community-onset primitive acute pyelonephritis 83
Uremic toxicity and anemia 82
A new polymethylmethacrylate membrane for hemodialysis 82
Update sull'impiego della proteomica in emodialisi 80
Proteomic Investigations into Hemodialysis Therapy 80
Effect of erythropoietin on primed leucocyte expression profile. 80
Use of oral hypoglycemic agents in patients with chronic kidney failure 77
Biocompatibility and functional performance of a polyethylene glycol acid-grafted cellulosic membrane for hemodialysis 77
Erythrocyte alterations and increased cardiovascular risk in chronic renal failure 77
Biocompatibility of DIAPES 75
Wireless capsule endoscopy in the diagnostic of small intestine angiodysplasia in chronic uremic patient 74
Nitric oxide synthetic pathway and cGMP levels are altered in red blood cells from end-stage renal disease patients 74
Reduced nitric oxide bioavailability in chronic renal failure: a new factor of progression? 73
Removal of uremic plasma factors using different dialysis modalities 73
Beta2-microglobulin causes abnormal phosphatidylserine exposure in human red blood cells. 73
Examining hemodialyzer membrane performance using proteomic technologies 73
Dislipidemia e progressione della insufficienza renale cronica 72
Vascular inflammation in end-stage renal disease: the red blood cell connection 72
Prevalence and associated variables of postdialysis fatigue: results of a prospective multicenter study 72
Effect of peritoneal dialysis fluid containing osmo-metabolic agents on human endothelial cells 72
Effetto ipolipemizzante della simvastatina nei pazienti in CAPD con ipercolesterolemia 71
Platelet activation markers in patients with nephrotic syndrome: A comparative study of different platelet function tests 71
Calcium Sensing Receptor activation by calcimimetic R-568 in human amniotic fluid mesenchymal stem cells: Correlation with osteogenic differentiation. 71
Terapia ipolipemizzante nella insufficienza renale cronica 70
Emodiafiltrazione con polisulfone: effetti elettrofisiologici sulla neuropatia uremica 70
Thyroid function and selenium supplementation in dialytic patients affected by chronic renal failure 70
L-Carnitine is an osmotic agent suitable for peritoneal dialysis 70
Carnitine in metabolic disease: potential for pharmacological intervention 69
Emodiafiltrazione (HDF) con membrane in polisulfone (PSF) ed eritropoietina ricombinante umana (r-HuEPO): si puo' fare di meglio? 69
In vitro microbiology studies on a new peritoneal dialysis connector 68
Metabolic Syndrome in Survivors from the 2009 Earthquake in Italy 68
Defining the potential antidepressant mode of action of acetyl-l-carnitine. 68
Removal of uraemic plasma factor(s) using different dialysis modalities reduces phosphatidylserine exposure in red blood cells. 68
Alterazioni del trasporto di Na+ e Ca++ in sinaptosomi di encefalo di ratto uremico: vi è correlazione con la trasmissione sinaptica? 66
Enhanced adherence of human uremic erythrocytes to vascular endothelium: role of phosphatidylserine exposure 66
Leukocyte adhesion molecules and leukocyte-platelet interactions during hemodialysis: effects of different synthetic membranes 66
Toward personalized hemodialysis by low molecular weight amino-containing compounds: future perspective of patient metabolic fingerprint 66
Calcimimetic R-568 and its enantiomer s-568 increase nitric oxide release in human endothelial cells 66
Extra-hepatic manifestations associated with Hepatitis and virus infection 66
L-carnitine in uremic anemia 65
Recovery time after hemodialysis is inversely associated with the ultrafiltration rate. 65
Glomerulopathies associated with psoriasis: a report of three cases 65
Identification of trimethylamine N-oxide (TMAO)-producer phenotype is interesting, but is it helpful? 65
Miglioramento dell'attivita' elettrica cerebrale in pazienti uremici in trattamento emodialitico (RDT) dopo eritropoietina umana ricombinante (r-HuEPO) 64
New treatment approaches for the anemia of CKD 64
Sjogren’s syndrome associated with haemolytic-uraemic syndrome as presenting clinical manifestation: a case report 64
Blood cell proteomics in chronic kidney disease 64
Urinary Peptidomic Biomarkers in Kidney Diseases 64
Alterazioni ematologiche nelle malattie renali e alterazioni renali in corso di malattie ematologiche 63
Watch out for lumbosciatalgy 63
Carnitine palmitoyltransferase as a potential target for treating diabetes: is inhibition or activation preferable? 62
Red blood cells may contribute to hypercoagulability in uraemia via enhanced surface exposure of phosphatidylserine 62
Biocompatibility assessment of haemodialysis membrane materials by proteomic investigations 61
Acetylcholine and acetylcarnitine transport in peritoneum: Role of the SLC22A4 (OCTN1) transporter 61
Dialysis practice and patient outcome in the aftermath of the earthquake at L'Aquila, Italy, April 2009 61
Effects of selenium supplementation on immune parameters in chronic uraemic patients on haemodialysis 61
Phenotypic characterization of kidney infiltrating cell subsets in idiopathic acute interstitial nephritis associated with uveitis: evidence for a cell-mediated immune disease 60
Variazioni elettrofisiologiche cerebrali indotte dal trattamento con eritropoietina ricombinante umana (r-HuEPO) in pazienti in trattamento emodialitico convenzionale (RDT) 60
Management of IgA nephropathy 60
Prevalence and severity of postdialysis fatigue are higher in patients on chronic hemodialysis with functional disability 60
L-Carnitine status in end-stage renal disease patients on automated peritoneal dialysis 60
Effetto protettivo dei Ca++-antagonisti (CCB) sulla nefrotossicità da ciclosporina (CyA) 59
Endoscopy as a tool for diagnosing and treating gastrointestinal angiodysplasia in haemodialysis patients 59
Increased erythrocyte phosphatidylserine exposure in chronic renal failure 59
Calcimimetic R-568 and its enantiomer induce a rapid, reversible, and only partially endothelium-mediated vasodilation in perfused mesenteric arteries from normotensive and spontaneously hypertensive rats 59
null 59
Selenium in uremia 58
Lipidi ed uremia 58
Cell-associated adhesion molecules as early markers of bioincompatibility 58
Proteomic analysis of protein adsorption onto haemodialysis membranes 58
Erythropoietin induces miRNA-210 by JAK2/STAT5 signaling in PBMCs of End-stage Renal Disease patients 58
null 58
Platelet-neutrophil interactions during hemodialysis: a proposed biocompatibility approach 57
Prevention of peritoneal sclerosis: a new proposal to substitute glucose with carnitine dialysis solution (biocompatibility testing in vitro and in rabbits) 57
Current opinion on usage of L-carnitine in end-stage renal disease patients on peritoneal dialysis 57
Totale 7602
Categoria #
all - tutte 25353
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25353


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018351 0000 00 00 691324326
2018/20191620 42132625 46244 24679 271031615
2019/20203244 92724468181 276189 361275 12330826329
2020/20211815 2481524844 159335 1795 15327299130
2021/20221158 662833206 8122 2576 10342146330
2022/20233121 340393153332 289641 291239 443000
Totale 13515